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Abstract 
Dermatofibroma is a common benign fibrohistiocytic lesion that usually appears as a 
slow-growing, firm dermal nodule with a predilection for the legs of middle-aged 
women. They are usually smaller than 2 cm in diameter. Many histological variants have 
been described. Generally, the clinical and histological diagnosis is straightforward, but 
differentiating it from other cutaneous tumors can be difficult in atypical cases and rare 
variants. Giant dermatofibroma is a rare clinical variant of dermatofibroma and less than 
25 cases have been reported. It is characterized essentially by its unusually large size, 
which often mimics malignant tumors clinically. We first present the case of a giant 
hemosiderotic dermatofibroma in a 54-year-old patient, who presented with a large 
ulcerated mass of the left foot which was excised, and then review the literature briefly. 
Introduction 
Dermatofibroma (DF; fibrous histiocytoma) is a spectrum of benign fibrohistiocytic 
tumors, which presents with a wide variety of clinical and histopathological features. Most 
measure between 0.5 and 2 cm, are often found on the limbs and trunk and can be 
recognized clinically by pinching the suspected nodule between the finger and thumb and 
observing that it is fixed within the dermis. It is usually asymptomatic, although pruritus 
and tenderness are not uncommon. Removal of the tumor is not necessary unless 
diagnostic uncertainty exists or disturbing symptoms are present. Giant DF, in contrast, is 
a very uncommon variant, larger than 5 cm and often polypoid, and the clinical diagnosis 
is obscure. We present a case of a giant DF (hemosiderotic type), in a 54-year-old patient, 
and review the literature on the condition briefly.  
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A 54-year-old patient, known to have type 2 diabetes, presented with a large ulcerated mass of the 
left foot. The lesion had been present for about 20 years and had initially been pea-sized. Over the last 
one a half years before case presentation, its size had increased up to 5 cm, and it had become painful 
and ulcerated. A similar 1-cm lesion was also present on the right leg (fig. 1a). Surgical resection of the 
mass and total skin graft were performed. One and a half years after surgery, the patient is well and has a 
healthy-looking scar with no signs of recurrence (fig. 1b). 
Macroscopic examination showed a large ulcerated cutaneous mass, measuring 5.1 × 4 × 1.5 cm (fig. 
2a). It had a pedunculated appearance with a large circular stalk measuring 3 cm. On cut section, the 
mass was solid and heterogeneous with white and brown areas (fig. 2b). No necrosis or cysts were seen. 
Histological examination revealed an ill-defined dermal proliferation of elongated fibrohistiocytic cells. 
Cellularity was variable with hypocellular and collagenized areas alternating with more cellular areas, 
sometimes of storiform pattern (fig. 3a). Some occasional moderate nuclear atypia was seen. No mitotic 
activity or necrosis was found. There were some giant multinucleated (Touton-like) cells and numerous 
tumor cells with brown hemosiderin pigment (positive with Prussian blue stain) (fig. 3b). At the borders 
of the lesion, collagenous nodules were seen entrapped between tumor cells. There was a grenz zone 
between the tumor and the overlying epidermis, which was focally ulcerated. The histological diagnosis 
was giant hemosiderotic DF. 
Discussion 
Typical DF are usually smaller than 3 cm. Usually, the clinical and histological 
diagnosis is simple, but distinguishing it from other cutaneous tumors can be difficult in 
atypical cases and rare variants. Giant DF is a rare clinical variant of DF which is 
characterized by its unusually large size. The following characteristics have been accepted 
for giant DF [1, 2]: (a) a size of ≥5 cm, (b) pedunculated appearance, (c) benign biological 
behavior despite its size, and (d) the same histopathological characteristics as 
conventional DF. If those criteria are applied, only 23 cases of giant DF have been 
described previously in the literature. They usually present as exophytic lesions, up to half 
of which are pedunculated. Most frequently, they are located on the legs, especially below 
the knee and on the foot, followed by location on the back [1–3]. Because of their large 
size, the correct diagnosis is frequently not reached from clinical examination alone, and a 
diagnosis of malignancy is often made. The differential diagnosis usually includes 
malignant lesions such as basal cell or epidermoid carcinoma, dermatofibrosarcoma 
protuberans or other sarcomas. However, histopathological study confirms the diagnosis 
by demonstrating the typical characteristics of DF. The varied histological spectrum seen 
in usual DF can also be seen in giant DF [4, 5]. Xanthomatous cells are present in up to 
half of the cases [2].  
Giant DF have also been reported with atypical/pleomorphic, lipidized, granular cells 
[6] and combined histological characteristics [2]. Some alleged cases of giant DF reported 
in the literature are in fact aneurysmal DFs [7, 8]. This is another uncommon histologic 
variant. It is usually larger than typical DF and may show rapid growth, mainly due to the 
presence of numerous blood-filled cavernous cavities and hemorrhage, often within the 
background of a hemosiderotic DF. In our case, the macroscopic brown color and 
numerous hemosiderophages seen microscopically correspond to a hemosiderotic 
variant.  
The histopathological features of several variants may also coexist in the same lesion 
and may correspond to different stages of the same disease. Some authors consider  
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hemosiderotic DF a precursor lesion in the development of aneurysmal DF [9, 10]. Our 
case, illustrating a giant hemosiderotic DF, is in agreement with this theory. To our 
knowledge, only one case of hemosiderotic giant DF has been reported but has not been 
illustrated previously [1, 2]. Giant DF can appear de novo or secondary from a pre-
existing and longstanding smaller lesion [5, 8] such as was the case in our patient. The 
origin (reactive or neoplastic) of DF including its giant variant is still unclear and debated. 
Some authors think that it is neoplastic because of the persistent nature of the lesion and 
the fact that the proliferating cells are clonal [11, 12]. However, clonality can also be seen 
in reactive and inflammatory conditions, including atopic dermatitis, lichen sclerosis, and 
psoriasis. Because of its fibrohistiocytic nature, the persistence of the lesion is not proof of 
its neoplastic nature and may be partly attributed to intrinsic fibrosis which does not 
usually regress, as it is the case for scars; neither is the fact that some DF can be 
gigantesque and larger than 5 cm decisive in that question since large size and rapid 
growth can be seen in other reactive processes/tumors such as nodular fasciitis. It is likely 
that DF is a heterogeneous process. The clonal genotype found in DF with histiocytoid or 
predominant histiocytoid features suggests that histiocytoid cells probably represent the 
neoplastic component [12]. Conversely, the fibroblastic form of DF may represent a 
reactive fibroblastic proliferation. Alternatively, it may represent a true neoplasm whose 
neoplastic cell type has been obscured by a prominent reactive fibroblastic component 
[12]. No recurrence has been reported after complete surgical excision of giant DF.  
In conclusion, we report another rare and interesting variant of giant DF, which is 








Fig. 1. a Small reddish cutaneous nodule on the right leg, consistent with DF. b Appearance of the scar 
1.5 years after surgery. 
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Fig. 2. a Large polypoid and ulcerated cutaneous mass excised from the patient’s leg. b On cut section, 




Fig. 3. a Histology shows a proliferation of fibrohistiocytic cells with a focal storiform pattern. Some 
cells contain brown granular hemosiderin pigment (HE, ×200). b The pigment is positive with Prussian 
blue stain (×400). 
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